Deborah J. Wexler MD, MSc
Associate Professor of Medicine, Harvard Medical School; Chief, Diabetes Unit, Massachusetts General Hospital, Boston, MassachusettsDr. Deborah J. Wexler's research focuses on clinical effectiveness in type 2 diabetes. In addition, she is on the Editorial Board of Diabetes Care, and is a reviewer for multiple journals.
Disclosures
Dr. Wexler reports serving on Data Monitoring Committees for trials of oral semaglutide sponsored by Novo Nordisk.
Recent Contributions to PracticeUpdate:
- Use of Rescue Insulin in the GRADE Study
- Comparative Effects of Randomized Second-Line Therapy for Type 2 Diabetes on Glycemic Control, Body Weight, and Hypoglycemia in GRADE
- Effects of Type 2 Diabetes Treatment Regimens on Diabetes Distress and Depressive Symptoms in GRADE
- Extension Study of the DiRECT Trial of Continued Support for Weight Loss Maintenance in the UK
- Cardiovascular Outcomes Associated With Glucose-Lowering Medications in Patients With Type 2 Diabetes
- 2023 Top Story in Diabetes: The STEP-HFpEF Trial
- Glycemic Outcomes of a Family-Focused Intervention for Adults With Type 2 Diabetes
- Dietary Patterns, Socioeconomic Disparities, and Risk of Type 2 Diabetes
- Impact of Neighborhoods on Diabetes Risk and Outcomes
- Food Insecurity and Diabetes